Breaking News Instant updates and real-time market news.

MDT

Medtronic

09:10
04/09/18
04/09
09:10
04/09/18
09:10

Medtronic announces renal denervation pivotal trial for hypertension treatment

Medtronic announced U.S. Food and Drug Administration approval to begin an investigational device exemption pivotal trial to evaluate the Symplicity Spyral renal denervation system in patients with high blood pressure. Renal denervation is a minimally invasive procedure intended to regulate the activity of nerves that lead to and from the kidney, which plays an important role in managing blood pressure. The SPYRAL HTN Pivotal Trial is part of the broader SPYRAL HTN Global Clinical Program, a multi-phased clinical study strategy aimed to establish the safety and efficacy of renal denervation to lower blood pressure.The SPYRAL HTN Pivotal Trial is a 1:1 randomized, sham-controlled study to investigate the renal denervation procedure in up to 433 patients at 50 sites in the U.S., Europe, Australia, and Japan. The trial will investigate the blood pressure lowering effect and safety of renal denervation in the absence of medication. The primary efficacy and safety endpoints in the trial are 24-hour blood pressure at three months and incidence of major adverse events through one-month post-randomization. In addition to the results from the SPYRAL HTN-OFF MED trial and the initiation of the SPYRAL HTN Pivotal Trial, new data from the first 80 patients enrolled in the prospective, randomized, sham-controlled SPYRAL HTN-ON MED trial will be presented during the late-breaking clinical trial session at the EuroPCR meeting commencing in May 2018 in Paris, France. This latest phase of the SPYRAL HTN Global Clinical Program will report the initial safety and efficacy of renal denervation six months following the procedure in patients with uncontrolled hypertension despite ongoing drug therapy.

  • 10

    Apr

  • 11

    Apr

  • 12

    Apr

  • 18

    Apr

  • 19

    Apr

  • 18

    May

MDT Medtronic

03/16/18
NEED
03/16/18
DOWNGRADE
NEED
Underperform
Mazor Robotics downgraded to Underperform from Hold at Needham
Needham analyst Mike Matson downgraded Mazor Robotics (MZOR) to Underperform from Hold, forecasting a "significant" slowdown in the company's growth this year as well as more intense competition in the robotics space. Matson adds that Mazor's valuation is priced to a "best case scenario" that is unlikely to be achieved while an acquisition by Medtronic (MDT) is also "extremely unlikely".
03/12/18
PIPR
03/12/18
NO CHANGE
PIPR
Overweight
Medtronic FDA news a 'nice win' for Dexcom in near-term, says Piper Jaffray
Piper Jaffray analyst JP McKim noted that Medtronic's (MDT) Guardian Connect system received FDA approval, but did not receive a non-adjunctive claim, which Dexcom (DXCM) and Abbott's (ABT) Libre have. The Guardian Connect system will not get Medicare coverage because of this, said McKim, who called the news a "nice win" for Dexcom in the near-term. While Kim does see Medtronic's system getting the claim eventually, he does not expect the Guardian Sensor to be a material threat to Dexcom in 2018 on a standalone basis, calling Medtronic a "pump first company." He keeps an Overweight rating on Dexcom shares.
03/12/18
WBLR
03/12/18
NO CHANGE
WBLR
Outperform
Insulet announced coverage win with UnitedHealth, says William Blair
Insulet (PODD) on Friday announced it had established a new contract with UnitedHealthcare (UNH), which would provide its patients with in-network, durable medical equipment coverage for Omnipod beginning April 1, William Blair analyst Margaret Kaczor tells investors in a research note. This is another coverage win for Insulet as UnitedHealth represents almost 50M lives in the United States, the analyst adds. She notes Insulet has had limited access to historically a Medtronic (MDT) has been UnitedHealth's preferred, in-network DME insulin pump provider since mid-2016. Kaczor views the announcement as "another improvement in patient access to Omnipod." She thinks Insulet "continues to fire on all cylinders" and keeps an Outperform rating on the shares.
02/26/18
PIPR
02/26/18
NO CHANGE
Target $60
PIPR
Overweight
Medtronic news incremental negative for Dexcom, says Piper Jaffray
Medtronic (MDT) this morning announced it received a new arm indication for its Guardian Sensor 3 which improves the accuracy of the sensor to an 8.7% MARD, likely leading to a non-adjunctive claim for standalone, Piper Jaffray analyst JP McKim tells investors in a research note. The news is an incremental negative for Dexcom (DXCM) shares as a path to non-adjunctive claim for Medtronic has become much clearer, McKim contends. He expects a stand-alone launch of Guardian Sensor 3 sometime in 2018. The analyst believes Dexcom carries more negative headline risk in the near term, but he expects the company to remain the market leader in continuous glucose monitors. As such, McKim thinks longer term investors should be buying the stock. He keeps an Overweight rating on Dexcom with a $60 price target. The stock in morning trading is down 12c to $56.24.

TODAY'S FREE FLY STORIES

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

18:08
04/20/18
04/20
18:08
04/20/18
18:08
Periodicals
North Korea to suspend nuclear and ICBM tests, Bloomberg reports »

North Korea also plans to…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

, BG

Bunge

$73.72

-1.935 (-2.56%)

18:03
04/20/18
04/20
18:03
04/20/18
18:03
Periodicals
Archer Daniels, Bunge talks end without merger deal, Bloomberg reports »

Advanced merger…

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

BG

Bunge

$73.72

-1.935 (-2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

CE

Celanese

$111.69

0.56 (0.50%)

18:02
04/20/18
04/20
18:02
04/20/18
18:02
Hot Stocks
Celanese announces price increases in Asia »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

IOTS

Adesto Technologies

$8.65

-0.2 (-2.26%)

17:33
04/20/18
04/20
17:33
04/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Adesto Technologies »

180 Degree Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SIGM

Sigma Designs

$6.30

0.1 (1.61%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Sigma Designs to delay filing Annual Report on Form 10-K »

Sigma Designs is unable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

, BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Breaking Hot Stocks news story on Berkshire Hathaway, Berkshire Hathaway, Torchmark »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

TMK

Torchmark

$87.22

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

, CG

Carlyle Group

$20.85

0.15 (0.72%)

17:17
04/20/18
04/20
17:17
04/20/18
17:17
Syndicate
SEACOR Marine Holdings announces $56.9M private placement of common stock »

SEACOR Marine Holdings…

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

CG

Carlyle Group

$20.85

0.15 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AVAV

AeroVironment

$56.66

-0.15 (-0.26%)

17:12
04/20/18
04/20
17:12
04/20/18
17:12
Hot Stocks
AeroVironment awarded $44.7M U.S. Army contract modification »

AeroVironment was awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

, XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

17:10
04/20/18
04/20
17:10
04/20/18
17:10
General news
Week ending ETF Scorecard: Energy outperforms again, Staples lag »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

IYR

DJ US Real Estate Index Fund

$73.94

-0.62 (-0.83%)

XLP

Consumer Staples Sector SPDR

$50.49

-0.85 (-1.66%)

XLY

Consumer Discretionary Sector SPDR

$102.97

-1.06 (-1.02%)

XLB

S&P Select Materials SPDR

$59.00

-0.36 (-0.61%)

XLF

Financial Select Sector

$27.89

0.015 (0.05%)

XLV

Health Care Select Sector SPDR

$82.10

-0.45 (-0.55%)

XLK

Technology Select Sector SPDR

$66.18

-0.97 (-1.44%)

XLI

Industrial Select Sector SPDR

$75.59

-0.32 (-0.42%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

SLV

iShares Silver Trust

$16.14

-0.11 (-0.68%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

UNG

United States Natural Gas Fund

$22.56

0.475 (2.15%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.91

-0.19 (-0.22%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.47

-0.49 (-0.42%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

-0.88 (-0.74%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.57

-0.355 (-0.35%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.03 (-0.04%)

IWD

iShares Russell 1000 Value

$121.38

-0.61 (-0.50%)

IWF

iShares Russell 1000 Growth

$137.65

-1.53 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.16

-0.0051 (-3.02%)

17:07
04/20/18
04/20
17:07
04/20/18
17:07
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$86.98

-0.9 (-1.02%)

, FB

Facebook

$166.29

-1.82 (-1.08%)

17:05
04/20/18
04/20
17:05
04/20/18
17:05
Hot Stocks
Walmart says Kevin Systrom will not stand for re-election to board »

Walmart and Systrom, the…

WMT

Walmart

$86.98

-0.9 (-1.02%)

FB

Facebook

$166.29

-1.82 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 25

    Apr

  • 17

    May

  • 30

    May

  • 01

    Jun

WMT

Walmart

$86.98

-0.9 (-1.02%)

, MCD

McDonald's

$158.77

-0.76 (-0.48%)

17:03
04/20/18
04/20
17:03
04/20/18
17:03
Hot Stocks
Walmart announces McDonald's Steve Easterbrook as independent nominee to board »

"This year's…

WMT

Walmart

$86.98

-0.9 (-1.02%)

MCD

McDonald's

$158.77

-0.76 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 30

    Apr

  • 17

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

, USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

17:00
04/20/18
04/20
17:00
04/20/18
17:00
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.5K…

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

FXE

Euro Currency Trust

$118.04

-0.65 (-0.55%)

FXC

CurrencyShares Canadian Dollar Trust

$77.37

-0.54 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.86

0.01 (0.35%)

16:59
04/20/18
04/20
16:59
04/20/18
16:59
Syndicate
Breaking Syndicate news story on Citius Pharmaceuticals »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
04/20/18
04/20
16:55
04/20/18
16:55
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

FPI

Farmland Partners

$7.85

-0.24 (-2.97%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Syndicate
Breaking Syndicate news story on Farmland Partners »

Farmland Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$8.85

0.05 (0.57%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

PVAM Perlus Microcap Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:46
04/20/18
04/20
16:46
04/20/18
16:46
Syndicate
American Midstream Partners files $150M preferred unit offering »

The offering is for $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:41
04/20/18
04/20
16:41
04/20/18
16:41
Syndicate
American Midstream Partners requests withdrawal of registration statement »

The Partnership has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSC

Seven Stars Cloud Group

$2.67

-0.1 (-3.61%)

16:40
04/20/18
04/20
16:40
04/20/18
16:40
Syndicate
Breaking Syndicate news story on Seven Stars Cloud Group »

Seven Stars Cloud Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:39
04/20/18
04/20
16:39
04/20/18
16:39
Hot Stocks
HNI Corporation CEO says 'seeing increased inflationary pressures' »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:38
04/20/18
04/20
16:38
04/20/18
16:38
Earnings
HNI Corporation narrows FY18 adjusted EPS view to $2.40-$2.70 from $2.40-$2.80 »

FY18 consensus $2.54. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:35
04/20/18
04/20
16:35
04/20/18
16:35
Earnings
HNI Corporation sees Q2 adjusted EPS 28c-38c ex-costs, consensus 56c »

Sees Q2 organic revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

WHR

Whirlpool

$149.43

-2.505 (-1.65%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Whirlpool »

Whirlpool files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GEL

Genesis Energy

$21.24

0.065 (0.31%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Genesis Energy »

Genesis Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.